retatrutide blindness Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial Retatrutide and Thyroid Cancer: Why

How Autoimmune Disease Can Raise Heart Risk Autoimmune disease may increase heart risk through chronic inflammation

Richards P, Parker HE, Adriaenssens AE, Hodgson JM, Cork SC, Trapp S, et al

[DOI] [PubMed] [Google Scholar] 66.Chia CW, Carlson OD, Kim W, Shin YK, Charles CP, Kim HS, Melvin DL, Egan JM

London: CoSRH (2024)

2023, www.uptodate.com/contents/glucagon-like-peptide-1-based-therapies-for-the-treatment-of-type-2-diabetes-mellitus/print?search=tirzepatide&source=search_result&selectedTitle=1~5&usage_type=default&display_rank=1

A randomized Phase 2a trial published in Nature Medicine demonstrated significant reductions in liver fat content in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)